Metamizol Noridem

Metamizole sodium, the active ingredient in Metamizol Noridem, is a pyrazolone presented as an injectable solution for intramuscular and intravenous use. It treats pain and fever, including postoperative pain, in adult patients.

GNH USA supplies Metamizol Noridem as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metamizole sodium is used for managing pain and fever through its analgesic and antipyretic actions.

Pain: provides relief of moderate to severe acute pain Fever: reduces elevated body temperature in febrile conditions Postoperative pain: controls pain following surgical procedures

Metamizole Noridem may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Injection site pain - Nausea - Dizziness - Transient hypotension

Serious or Rare Side Effects: - Agranulocytosis - Severe allergic reactions (anaphylaxis) - Stevens‑Johnson syndrome

Prior to initiating therapy, clinicians should consider several safety measures.

Assess blood counts before therapy: monitor for neutropenia Use with caution in renal impairment: adjust monitoring Avoid in known hypersensitivity to pyrazolones: contraindicated Administer only under medical supervision: ensure appropriate indication Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake

Metamizole Noridem can interact with other medicines, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Concomitant myelosuppressive agents: increased risk of agranulocytosis - ACE inhibitors: may potentiate hypotension - Other NSAIDs: additive gastrointestinal and renal risk

Moderate Interactions (Monitor Closely): - Anticoagulants: increased bleeding tendency - Diuretics: possible electrolyte disturbances - Other antipyretics: may mask fever response